Dyrness Albert D. 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Apr 8, 2022
Insider Transaction Report
Form 4
Dyrness Albert D.
Director
Transactions
- Award
Common Stock
2021-12-15+14,152→ 27,123 total
Footnotes (1)
- [F1]On December 15, 2021, the Reporting Person was granted 14,152 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2023.